Zenzium is a Health & Biomedical Data Science Company that provides actionable intelligence to enhance care outcomes for individuals with chronic medical conditions. By harnessing the power of artificial intelligence and deep learning, Zenzium discovers and extracts relevant information from large complex datasets, both proprietary and open-source. They specialize in chronic diseases, particularly respiratory conditions like Chronic Obstructive Pulmonary Disease (COPD), asthma, and Cystic Fibrosis (CF).

Zenzium's approach involves using deep learning technology to identify and predict exacerbations, which is crucial for managing these diseases and preventing hospitalizations. Their expertise extends beyond respiratory conditions to other chronic diseases such as Cardiovascular Disease (CVD), diabetes, arthritis, stroke, multiple sclerosis (MS), and neurodegenerative conditions like Alzheimer's. Zenzium's innovative solutions find application in the pharmaceutical industry, healthcare delivery, and self-management, helping improve patient outcomes, reduce healthcare costs, and optimize scarce resources.

With their Artificial Intelligence (AI) approach and deep learning technology, Zenzium is revolutionizing the way chronic diseases are managed